Alto Ingredients: Strong Margin Expansion Is Driving Above-Average Earnings Growth
Alto Ingredients is attractively valued, with strong multi-year earnings growth potential and a low forward PE ratio. ALTO benefits from favorable U.S. renewable fuel standards along with Section 45Q and 45Z tax credits. Operational improvements, including an 8% capacity increase at Pekin and expanded CO2 storage, support higher-margin growth and incremental tax credit eligibility.
Alto Neuroscience: Buy ALTO-207 Advancement TRD And Other Expansion Indications
Alto Neuroscience maintains a 'Buy' rating, driven by the potential of ALTO-207 for treatment-resistant depression [TRD] and robust cash reserves. ALTO-207, a pramipexole/ondansetron combination, targets TRD with phase 2b topline data expected in 2H 2027 and possible phase 3 initiation by early 2027. Despite ALTO-100's phase 2b failure in MDD, ANRO's diversified pipeline and biomarker-driven strategies support continued optimism.
How Alto Ingredients Plans to Monetize Every Ton of Biogenic CO2
ALTO is expanding premium CO2 sales while evaluating utilization and sequestration to unlock more value from ethanol byproducts.
Could E15 Adoption Unlock Alto Ingredients' Next Growth Phase?
ALTO could gain from broader year-round E15 sales, which may lift ethanol demand as operations improve and 45Z credits support production.
ALTO Trades at a Discount Despite 344% Rally in a Year: What's Next?
ALTO's strong rally reflects improving profitability, favorable market trends and growth initiatives, while its valuation remains attractive.
Can Debottlenecking Drive Alto Ingredients' Next Growth Phase?
ALTO is pursuing a targeted plant upgrade to boost production, improve efficiency and capture more clean fuel tax benefits.
Can Alto Ingredients Sustain Its Return to Profitability Momentum?
ALTO's first-quarter 2026 return to profitability reflects stronger exports, higher crush margins, richer product mix and operating improvements.
Alto Ingredients, Inc. (ALTO) Hits Fresh High: Is There Still Room to Run?
Alto Ingredients (ALTO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Alto Ingredients Is Expanding Pekin Production Capacity
ALTO is expanding its Pekin dry mill to boost production, improve efficiency and strengthen profitability through operational upgrades.
Can Biogenic CO2 Become Alto Ingredients' Next Growth Business?
ALTO is building a growth opportunity around biogenic CO2 through expanded storage capacity and potential Section 45Z tax-credit benefits.
Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?
Here is how Alto Ingredients (ALTO) and Central Garden (CENT) have performed compared to their sector so far this year.
Alto Ingredients vs. Green Plains: Which Stock Offers More Upside?
ALTO and GPRE are pursuing different biofuel strategies as ethanol producers navigate corn prices, policy shifts and low-carbon demand.
